DTMC
NIDA-CPU-0010
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine
Louis Cantilena, Jr., M.D, Ph.D.
Jun 03, 2020
DTMC
NIDA-MDS-0002
Assessment of Interactions Between Methamphetamine and Aripiprazole
Thomas F. Newton, M.D.
May 07, 2018
DTMC
NIDA-CTO-0010
Assessment of Potential Interactions Between Methamphetamine and Bupropion
Thomas F. Newton, M.D.
May 07, 2018
DTMC
NIDA-MDS-0003
Phase I, Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Cocaine And Ethanol And Oral Disulfiram
John D. Roache, Ph.D.
Dec 21, 2017
DTMC
NIDA-CPU-0008
Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil
Reese Jones, M.D.
Dec 21, 2017
DTMC
NIDA-CPU-0004
Study of Interactions Between GBR 12909 and Cocaine
Kathryn Cunningham, Ph.D. , John Grabowski, Ph.D.
May 23, 2017
DTMC
NIDA-CPU-0006
A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine
Reese Jones, M.D.
May 23, 2017
DTMC
NIDA-CPU-0003
Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681
Louis Cantilena, Jr., M.D, Ph.D.
May 23, 2017
DTMC
NIDA-CPU-0002
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers
Louis Cantilena, Jr., M.D, Ph.D.
May 23, 2017
DTMC
NIDA-CTO-0006
Cocaine-Metyrapone Interaction Study
Bonita Singal, M.D. , T. John Winhusen, Ph.D.
Aug 01, 2016
DTMC
NIDA-CTO-0004
Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline
Thomas F. Newton, M.D.
Aug 01, 2016
DTMC
NIDA-CTO-0003
Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone
Thomas F. Newton, M.D.
Aug 01, 2016
DTMC
NIDA-CTO-0002
Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine
Robert J. Malcolm, M.D. , C. Lindsay DeVane, Pharm.D.
Aug 01, 2016
DTMC
NIDA-CPU-0016
Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Methamphetamine And Osmotic-Release Methylphenidate (Oros-Mph)
Eugene Somoza, M.D.
Dec 04, 2014